OPEN END TURBO OPTIONSSCHEIN LONG - AMGEN | Real-time BOERSE MUENCHEN 11:56:31 28/06/2024 pm IST | ||
| 10.48 EUR | +0.48% |
|
| 1 month | +13.30% | ||
| 3 months | +28.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 10.48 | +0.48% |
| 27/24/27 | 10.43 | -1.60% |
| 26/24/26 | 10.6 | -5.53% |
| 25/24/25 | 11.22 | +3.79% |
| 24/24/24 | 10.81 | +5.16% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 11:56 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GP4Z84 |
| ISIN | DE000GP4Z849 |
| Date issued | 26/05/2023 |
| Strike | 200.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.91 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.16 € |
|---|---|
| Lowest since issue | 2.498 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
